Embedded Files
3rd Kyoto University LifeScience Showcase
March 1, 2022 2- 5:30pm (PST)
March 2, 2022 7-10:30am (JST)
Start-ups stemming from academia who have state-of-the-art innovations with solid science and technologies will participate the event, and present their novel technologies and seeds in the life science fields including pharmaceuticals, regenerative medicine, medical devices, and diagnostics. Participants who are interested in investing on medical area innovations will be welcomed.
Registration fee : Free
contact : info@kurcsd.com
Program
* The program is subject to change.
* At the end of each presentation, we will ask everyone to vote for their evaluation and the results will be used to determine the Audience Award.
2:00pm(PST) Opening remarks
2:05pm(PST) Session1 “Immunology and infectious diseases” sponsored by Kyoto University
Rebirthel Co., Ltd.
Development of off-the-shelf T cell therapy for cancer and viral infection using the iPS cell technology
SUDx-Biotec Corporation
Chimeric Antigen Receptor expressed Natural iller Cells for the treatment of Adult T-cell Leukemia (CAR-NK for ATL)
( please use "Translate" )
2:50pm(PST) Session 2 "Medical devices" sponsored by LINK-J
Lilac pharma Inc.
Our microfluidic technology unlocks a future of individualized mRNA vaccine therapy
3:35pm(PST) Session 3 "Small molecules and oligonucleotides" sponsored by FBRI
Takaha Pharma Co. Ltd.
Development of ATP enhancer [a combination drug of febuxostat and inosine] effective for mitochondrial disease, Parkinson's disease, and dementia
NATiAS Inc.
Contributing to Global Healthcare through Innovation of Oligonucleotide Synthesis Technology
4:20pm(PST) Session 4 "Regenerative medicine" sponsored by JETRO
5:05pm(PST) Award ceremony
5:20pm(PST) Closing remarks
5:25pm(PST) Adjourn
Commentators
Paul Roben, Ph.D.
Associate Vice Chancellor, Innovation and Commercialization, UC San Diego
Petra Stegmann, Ph.D.
Senior Director, Springboard Accelerator Program at CONNECT
Jay Kunin, Ph.D.
Adjunct Professor of University of San Diego, Boards of PharmaSecure, Inc. and Sironis, Inc
Rieko Yajima, Ph.D.
Director, Drug Discovery Innovation SPARK Program in Translational Research, Stanford University
Report abuse